Editas Medicine Profit Margin

Editas Medicine (EDIT) currently reports a profit margin of -167.4% as of June 2026. That compares with -691.7% in the prior-year period — up 75.8% year over year. That is below the Healthcare sector average of 9.71%. Use the charts on this page to explore Editas Medicine's profit margin history and peer comparisons.

Editas Medicine's profit margin increased from -691.7% to -167.4% — a 75.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Editas Medicine's profit margin of -167.4% is lower than the Healthcare sector average of 9.71%. That is roughly 1824.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Editas Medicine's current -167.4% should be judged against Healthcare norms (sector average: 9.71%) and against EDIT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -167.4%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.71%. From there, open related valuation or income-statement pages for Editas Medicine, and consider following EDIT for alerts when major investors trade the stock.